Literature DB >> 12817311

[Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents].

T Bernatik1, D Becker, D Neureiter, J Hänsler, M Frieser, S Schaber, E G Hahn, D Strobel.   

Abstract

AIM: To compare detection rates for liver metastases for conventional ultrasound, US using tissue harmonic imaging (THI), echo-enhanced pulse inversion harmonic imaging using Optison and Levovist.
METHOD: In 73 patients with histologically proven gastrointestinal tumors spiral CT (S-CT), conventional US, US in the THI-mode, echo-enhanced ultrasound in the portal venous phase (ECI Optison ) and in the liver specific late phase (ECI Levovist) were performed and reviewed by blinded readers.
RESULTS: 73 patients (25 female, 48 male, age 63 +/- 11) were included. S-CT detected 158 liver metastases. Conventional US detected 117, THI 119, ECI Optison 169 and ECI Levovist 166 liver metastases. Especially for small (< 2 cm) liver metastases and metastases near the diaphragm echo-enhanced ultrasound exceeded conventional US (p < 0.001). Between both echo enhancers there was no significant difference.
CONCLUSION: Using echo enhancers increases the ultrasound detection rate significantly. Examination in the portalvenous phase using a second generation enhancer (Optison) is equal to a late-phase examination using Levovist.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817311     DOI: 10.1055/s-2003-40060

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  7 in total

Review 1.  Contrast-enhanced and targeted ultrasound.

Authors:  Michiel Postema; Odd Helge Gilja
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

2.  Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.

Authors:  R Konopke; S Kersting; H Bergert; A Bloomenthal; J Gastmeier; H D Saeger; A Bunk
Journal:  Int J Colorectal Dis       Date:  2006-05-30       Impact factor: 2.571

Review 3.  [Diagnostic imaging of liver tumours. Current status].

Authors:  B Boozari; J Lotz; M Galanski; M Gebel
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

4.  Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI.

Authors:  Christoph F Dietrich; Wolfgang Kratzer; Deike Strobe; Etienne Danse; Robert Fessl; Alfred Bunk; Udo Vossas; Karlheinz Hauenstein; Wilhelm Koch; Wolfgang Blank; Matthijs Oudkerk; Dietbert Hahn; Christian Greis
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 5.  A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer.

Authors:  Jing Wang; Yanhua Chu; Baohua Wang; Tianan Jiang
Journal:  Cancer Manag Res       Date:  2021-10-14       Impact factor: 3.989

Review 6.  When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation?

Authors:  Markus Zeisbrich; Lars P Kihm; Felix Drüschler; Martin Zeier; Vedat Schwenger
Journal:  Clin Kidney J       Date:  2015-08-08

Review 7.  Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.

Authors:  Liliana Chiorean; Claudio Tana; Barbara Braden; Cosmin Caraiani; Zeno Sparchez; Xin-Wu Cui; Ulrich Baum; Christoph F Dietrich
Journal:  Med Princ Pract       Date:  2016-06-17       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.